Two simple and sensitive spectrophotometric methods have been developed for the determination of some anti-depressant drugs such as clomipramine (CLO) and paroxetine (PRX). The methods involved the formation of ion-pairs between the inorganic complexes of molybdenum(v) thiocyanate and hexakis iron(III) solution followed by extraction with 1,2-dichloroethane. The optimum conditions for the ion-pairs formation were established under which Beer , s low was obeyed for CLO and PRX in the concentration range 5-150 and 10-250 μg mL -1 for the first method, while it was obeyed for the second method in the concentration range of 10 -200 μg mL -1 for both CLO and PRX drugs, respectively. The limits of detection were 0.0744 and 0.109 μg mL -1 and 0.177 and 0.113 μg mL -1 for CLO and PRX using the first and second methods, respectively. The limits of quantification for the first method were 0.223 and 0.531 μg mL -1 while they were 0.327 and 0.340 μg mL -1 using the second method for CLO and PRX drugs, respectively. Both of the two methods have been successfully applied for the determination of the cited drugs in row materials and in drug formulations and compared with the official reference methods. Complete validation of the proposed methods was done.
. It could be also determined electrochemically using different techniques [7] [8] [9] .
Chromatographic techniques were suggested for the determination of the drug in row materials and in biological fluids using HPLC and different detectors [10] [11] [12] [13] [14] .
Fast LC-MS/MS method [15] , capillary gas chromatographic method with flame ionization detection was also used [16] as well as Capillary zone electrophoresis methods [17, 18] . Paroxetine was determined by different methods such as chromatographic methods [19] [20] [21] [22] [23] [24] [25] and electrochemical methods [26, 27] . Paroxetine was determined spectrophotometrically via charge transfer complex formation with TCNQ and other reagents [28] [29] [30] . This work was undertaken in order to study the analytical aspects of the reaction between the drugs under investigation with molybdenum(V)-thiocyanate and hexakis iron solutions. This also aims to test the sensitivity, accuracy and selectivity of the ion-pair formation methods to use them for the determination of the cited drugs in row materials and pharmaceutical preparations. The structures of CLO and PRX are shown in Figure ( 
Experimental Apparatus
A Perkin-Elmer spectrophotometer model 601 with matched quartz cell of 1.0 cm optical path length was used for spectrophotometric measurements at the wavelength range of 350-6oo nm.
Materials and Solutions
All reagents were of analytical grade and used without further purifications. The water used was always doubly distilled. CLO row material was supplied from Acapi 16 0 OPTIMIZED AND VALIDATED SPECTROPHOTOMETRIC … Co., Egypt. Anapramine 75 mg/tablet was supplied from Sigma pharmaceutical industries, Egypt. Anafranil 25 mg/tablet was supplied from Novartis, Egypt.
PRX row material was supplied from Elpheronea Co., Egypt. Paroxetine and xanadole (20 mg /tablet) were supplied from Eva pharma. and European Egyptian Pharm, Egypt, respectively. Their solutions (1mg mL -1 ) were freshly prepared by dissolving the drugs in methanol and kept at 4 ºC, in PVC containers, in the refrigerator. Other solutions were prepared by appropriate dilutions. Stock Mo(VI) solution (0.02% w/v) was prepared from AR grade ammonium molybdate in doubly distilled water containing a few drops of ammonia and standardized gravimetrically using 8-hydroxyquinoline [31] . Ammonium thiocyanate and ascorbic acid solutions (10% each) were prepared in doubly distilled water. Hexakis (thiocyanato) iron(III) solution (0.05M) was prepared by dissolving 1.34 g of FeCl3. 9H2O and 5.87 g of NH4SCN in 100 ml water (pH 1.8).
Tablets solutions
Ten tablets of CLO or also another ten of PRX were accurately weighed and the average weight of tablets was calculated. The tablets were crushed well to a fine were added and diluted with bidistilled water up to 20 mL. After 20 min., 10 mL of 1,2-dichloroethane was added (twice with 5 ml portions). The mixture was shaked well for 1 min and allowed to stand to separate into two phases. The ion pair was extracted with 1,2-dichloroethane (2 × 5 ml) and the absorbance of the filtered extract was measured at 470 nm for both CLO and PRX, respectively, against a reagent blank, which prepared similarly without the drug.
Determination of ClO and PRX via ion pair formation with hexakis(thiocyanato) iron (III) solution.
Aliquots of drug solutions (1mg mL -1 )were transferred in 50 mL separating funnel, 2 mL of 0.05 M Fe(SCN)6 -3 carrier solution, 2 mL of HCl (10 M) were added and the solution diluted with distilled water up to 10 mL, the mixture was left for 5 min at room temperature (20±1 ºC). 10 mL of 1,2-dichloroethane was added (twice with 5 ml portion). The mixture was shaked well for 1 min and allowed to stand to separate into two phases. The ion pair was extracted with 1,2-dichloroethane (2 × 5 ml) and the absorbance of the filtered extract was measured at 500 nm for CLO and PRX, respectively against a reagent blank prepared similarly without addition of drugs.
Results and discussion
This work is undertaken in the view that ion-pairs are formed between the tertiary amino group of PRX and CLO drugs and molybdenum(V)-or iron(III)-thiocyanate binary complexes via the protonated nitrogen atom of the drugs [32] . that, the reduction probability of Mo(VI) to Mo(V) may occur by ascorbic acid or SCN -in acidic media [33] . However, the rapidity, sensitivity and stability of Mo(V)-thiocyanate binary complex are enhanced by using ascorbic acid. Ascorbic acid
gives reproducible values and masks many of interfering ions [33] . From the data shown in Fig. (2) it is found that 16.8x10 4 µg mL -1 ascorbic acid is sufficient for the reduction of 56.6 µg mL -1 of Mo(VI) to Mo(V). The addition of excess amount of ascorbic acid, more than the required volume, has no effect on the absorbance of the ion-pairs formed. It was found that the ion pairs were formed only in hydrochloric acid, sulfuric, nitric or phosphoric acid medium, but the absorbance readings of 1,2- at λ max 500 nm for CLO and PRX, so it is selected as the best medium for extraction.
Reproducible absorbance readings were obtained after either single or double extractions with 10.0 mL of methylene chloride and 1 min shaking time. The studied ion-pairs are stable for more than 1 weak at 25 ºC in the organic solvents.
Analytical data and methods validation
In order to prove the validity and the applicability of the proposed methods and the reproducibility of the results obtained, five replicates experiments at four concentrations of CLO and PRX were carried out. Table (1) shows the values of the between day relative standerd deviations for different concentrations of the drugs, obtained from experiments carried out over a period of 4 days, it was found that the between day relative standard deviations were less than 1.0% which indicates that the proposed method is highly reproducible and Mo(V), iron(III) thiocyanate binary complexes are successfully applied to determine CLO and PRX via formation of ion pairs. Under the optimum conditions described above, the calibration graphs were constructed for both drugs. The molar absorptivity, Sandell sensitivity and regression equation obtained by the method of least square treatment of calibration data (n = 5) for each drug were tabulated in Tables (2) together with the calibration plots exhibited good linearity which supported the validation of the proposed procedure for the quantitation of the drugs. LOD and LOQ were calculated using the relation K (SDa)/b where K = 3 for LOD and 10 for LOQ [35] valued given in tables (2) confirming the high sensitivity of the proposed procedure compared to the official methods [36] .The repeatability of the methods were determined from multiple measurements at each of the studied samples by 16 4 OPTIMIZED AND VALIDATED SPECTROPHOTOMETRIC … performing five replicates measurements (n = 5). A mean recovery of 99 ± 0.5 was achieved, which indicates a high precision of the proposed procedure for assay of the drugs.
Application:
The validity of the proposed method was tested by determination of CLO and PRX in dosage forms manufactured in the local companies. The concentration of the drugs in the dosage forms was calculated from the appropriate calibration graphs. There was no shift in the absorption maximum due to the presence of other constituents of the dosage forms. Table ( 
Interferences
Interferences are mainly basic compounds that contain hetero nitrogen atoms in their aromatic nuclei; however, such compounds are not usually present with the examined drugs in pharmaceutical preparations and hence are not likely to cause analytical problems. On the other hand, tablets fillers such as lactose, starch, stearic acid and preservations used in their preparations which can represent a potential source of interference in other methods don't interfere in the proposed method. That is to say the proposed method can be considered to be selective.
Conclusion:
In conclusion, simple, sensitive and selective methods are reported for the determination of CLO and PRX drugs in bulk form and pharmaceutical preprations. The statistical parameters and recovery study data clearly indicate the reproducibility and accuracy of the method. From the calculated t and F values, it is clear that the results obtained are in good agreement with those obtained by official method. -Tabulated t-values at 95% confidence limit = 3.182 at degrees of freedom =3 -Tabulated F-values at 95% confidence limit = 9.12.
